Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1956 5
1957 5
1958 3
1959 2
1961 7
1962 13
1963 12
1964 11
1965 8
1966 16
1967 32
1968 15
1969 29
1970 18
1971 14
1972 25
1973 19
1974 37
1975 11
1976 28
1977 26
1978 10
1979 14
1980 15
1981 21
1982 18
1983 26
1984 24
1985 31
1986 26
1987 35
1988 38
1989 32
1990 42
1991 40
1992 39
1993 52
1994 55
1995 54
1996 48
1997 44
1998 50
1999 46
2000 46
2001 59
2002 52
2003 56
2004 61
2005 71
2006 61
2007 67
2008 63
2009 64
2010 50
2011 71
2012 82
2013 100
2014 81
2015 77
2016 86
2017 84
2018 99
2019 115
2020 132
2021 167
2022 142
2023 115
2024 113

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,953 results

Results by year

Filters applied: . Clear all
Page 1
Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial.
Mebazaa A, Davison B, Chioncel O, Cohen-Solal A, Diaz R, Filippatos G, Metra M, Ponikowski P, Sliwa K, Voors AA, Edwards C, Novosadova M, Takagi K, Damasceno A, Saidu H, Gayat E, Pang PS, Celutkiene J, Cotter G. Mebazaa A, et al. Among authors: takagi k. Lancet. 2022 Dec 3;400(10367):1938-1952. doi: 10.1016/S0140-6736(22)02076-1. Epub 2022 Nov 7. Lancet. 2022. PMID: 36356631 Clinical Trial.
Author's reply.
Iwama M, Noda T, Takagi K, Tanaka A, Murohara T. Iwama M, et al. Among authors: takagi k. J Cardiol. 2023 Nov;82(5):429-430. doi: 10.1016/j.jjcc.2023.08.015. Epub 2023 Sep 4. J Cardiol. 2023. PMID: 37666322 Free article. No abstract available.
NT-proBNP and high intensity care for acute heart failure: the STRONG-HF trial.
Adamo M, Pagnesi M, Mebazaa A, Davison B, Edwards C, Tomasoni D, Arrigo M, Barros M, Biegus J, Celutkiene J, Čerlinskaitė-Bajorė K, Chioncel O, Cohen-Solal A, Damasceno A, Diaz R, Filippatos G, Gayat E, Kimmoun A, Lam CSP, Novosadova M, Pang PS, Ponikowski P, Saidu H, Sliwa K, Takagi K, Ter Maaten JM, Voors A, Cotter G, Metra M. Adamo M, et al. Among authors: takagi k. Eur Heart J. 2023 Aug 14;44(31):2947-2962. doi: 10.1093/eurheartj/ehad335. Eur Heart J. 2023. PMID: 37217188 Clinical Trial.
Uptitrating Treatment After Heart Failure Hospitalization Across the Spectrum of Left Ventricular Ejection Fraction.
Pagnesi M, Metra M, Cohen-Solal A, Edwards C, Adamo M, Tomasoni D, Lam CSP, Chioncel O, Diaz R, Filippatos G, Ponikowski P, Sliwa K, Voors AA, Kimmoun A, Novosadova M, Takagi K, Barros M, Damasceno A, Saidu H, Gayat E, Pang PS, Celutkiene J, Cotter G, Mebazaa A, Davison B. Pagnesi M, et al. Among authors: takagi k. J Am Coll Cardiol. 2023 Jun 6;81(22):2131-2144. doi: 10.1016/j.jacc.2023.03.426. J Am Coll Cardiol. 2023. PMID: 37257948 Free article. Clinical Trial.
Safety, Tolerability and efficacy of Rapid Optimization, helped by NT-proBNP and GDF-15, of Heart Failure therapies (STRONG-HF): rationale and design for a multicentre, randomized, parallel-group study.
Kimmoun A, Cotter G, Davison B, Takagi K, Addad F, Celutkiene J, Chioncel O, Solal AC, Diaz R, Damasceno A, Duengen HD, Filippatos G, Goncalvesova E, Merai I, Metra M, Ponikowski P, Privalov D, Sliwa K, Sani MU, Voors AA, Shogenov Z, Mebazaa A. Kimmoun A, et al. Among authors: takagi k. Eur J Heart Fail. 2019 Nov;21(11):1459-1467. doi: 10.1002/ejhf.1575. Epub 2019 Aug 19. Eur J Heart Fail. 2019. PMID: 31423712 Free article. Clinical Trial.
Robotic Total Pancreatectomy: A Narrative Review.
Takagi K, Koerkamp BG. Takagi K, et al. In Vivo. 2021 Jul-Aug;35(4):1907-1911. doi: 10.21873/invivo.12456. In Vivo. 2021. PMID: 34182462 Free PMC article. Review.
Amended STRONG-HF study design.
Cotter G, Davison B, Metra M, Sliwa K, Voors AA, Addad F, Celutkiene J, Chioncel O, Cohen Solal A, Diaz R, Damasceno A, Duengen HD, Filippatos G, Goncalvesova E, Merai I, Ponikowski P, Privalov D, Sani MU, Takagi K, Shogenov Z, Saidu H, Mebazaa A. Cotter G, et al. Among authors: takagi k. Eur J Heart Fail. 2021 Nov;23(11):1981-1982. doi: 10.1002/ejhf.2348. Epub 2021 Oct 4. Eur J Heart Fail. 2021. PMID: 34529313 Free article. No abstract available.
No Antithrombotic Therapy After Transcatheter Aortic Valve Replacement: Insight From the OCEAN-TAVI Registry.
Kobari Y, Inohara T, Tsuruta H, Yashima F, Shimizu H, Fukuda K, Naganuma T, Mizutani K, Yamawaki M, Tada N, Yamanaka F, Shirai S, Tabata M, Ueno H, Takagi K, Watanabe Y, Yamamoto M, Hayashida K. Kobari Y, et al. Among authors: takagi k. JACC Cardiovasc Interv. 2023 Jan 9;16(1):79-91. doi: 10.1016/j.jcin.2022.10.010. Epub 2022 Dec 14. JACC Cardiovasc Interv. 2023. PMID: 36599591
Optimization of Evidence-Based Heart Failure Medications After an Acute Heart Failure Admission: A Secondary Analysis of the STRONG-HF Randomized Clinical Trial.
Cotter G, Deniau B, Davison B, Edwards C, Adamo M, Arrigo M, Barros M, Biegus J, Celutkiene J, Cerlinskaite-Bajore K, Chioncel O, Cohen-Solal A, Damasceno A, Diaz R, Filippatos G, Gayat E, Kimmoun A, Lam CSP, Metra M, Novosadova M, Pang PS, Pagnesi M, Ponikowski P, Saidu H, Sliwa K, Takagi K, Ter Maaten JM, Tomasoni D, Voors A, Mebazaa A. Cotter G, et al. Among authors: takagi k. JAMA Cardiol. 2024 Feb 1;9(2):114-124. doi: 10.1001/jamacardio.2023.4553. JAMA Cardiol. 2024. PMID: 38150260 Free PMC article.
2,953 results